FDA Clearance Tracker · K173648
Spectralis HRA + OCT and variants
Last checked: Nov 19, 2026Latest source record: Aug 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Aug 30, 2018
Substantially Equivalent
Time to decision
276 days
Received Nov 27, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K173648
- Device name
- Spectralis HRA + OCT and variants
- Applicant
- Heidelberg Engineering GmbH
- Applicant location
- Heidelberg, DE
- Received
- Nov 27, 2017
- Decided
- Aug 30, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Tomography, Optical Coherence (OBO)
- Device class
- Class II
- Regulation
- 21 CFR 886.1570
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OBO. The earliest in FDA's data is K062552, decided Oct 6, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173648
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Heidelberg Engineering GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ANTERION510(k)
K261019 · Decided Sep 11, 2026 · 168 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K253837 · Decided May 7, 2026 · 157 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
K250868 · Decided May 12, 2025 · 49 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.